addressing the challenge of bridging therapy in car-t in order to improve patient outcomes
Published 6 months ago • 60 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
3:07
the role of bridging and timing in car-t
-
3:03
the impact of salvage and bridging therapy on car t-cell therapy outcomes in b-all: an itt analysis
-
1:13
selecting car-t bridging therapy for patients with all
-
1:38
challenges of car-t therapy in the real-world setting
-
2:18
ven-aza versus intensive chemotherapy as bridging therapy in patients with mds
-
2:14
optimizing bridging therapy for car-t in children and young adults with r/r all
-
1:47
challenges in using car-t therapy & btk inhibitors in patients with r/r mcl
-
25:18
addressing the major challenges to car-t therapy in aml
-
4:22
radiotherapy: helen's experience
-
48:50
session 5 - how to fine-tune the commissioning of a tps
-
3:25
belantamab mafodotin and its place in myeloma treatment
-
4:00
the influence of bridging therapy on outcomes in large b-cell lymphoma
-
3:42
novel approaches to bridging prior to car-t therapy in multiple myeloma
-
1:38
predicting response to car-t therapy in lymphoma: challenges and strategies
-
2:25
does bridging therapy affect lymphoma car-t outcomes?
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
0:37
factors to consider when managing patients with all prior to car t-cell therapy
-
1:44
challenges in developing car-t therapy for aml
-
3:40
challenges that car-t therapy can present to patients
-
2:58
the impact of bridging therapy on the outcomes of patients with r/r myeloma treated with ide-cel
-
2:10
optimizing car-t therapy in lbcl
-
14:23
highlights from day 2: addressing challenges in car-t therapy for all, aml, cll & more…